Abstract:With the advent of make-on-demand commercial libraries, the number of purchasable compounds available for virtual screening and assay has grown explosively in recent years, with several libraries eclipsing one billion compounds. Today's screening libraries are larger and more diverse, enabling the discovery of more-potent hit compounds and unlocking new areas of chemical space, represented by new core scaffolds. Applying physics-based in silico screening methods in an exhaustive manner, where every molecule in the library must be enumerated and evaluated independently, is increasingly cost-prohibitive. Here, we introduce a protocol for machine learning-enhanced molecular docking based on active learning to dramatically increase throughput over traditional docking. We leverage a novel selection protocol that strikes a balance between two objectives: (1) identifying the best scoring compounds and (2) exploring a large region of chemical space, demonstrating superior performance compared to a purely greedy approach. Together with automated redocking of the top compounds, this method captures almost all the high scoring scaffolds in the library found by exhaustive docking. This protocol is applied to our recent virtual screening campaigns against the D4 and AMPC targets that produced dozens of highly potent, novel inhibitors, and a blind test against the MT1 target. Our protocol recovers more than 80% of the experimentally confirmed hits with a 14-fold reduction in compute cost, and more than 90% of the hit scaffolds in the top 5% of model predictions, preserving the diversity of the experimentally confirmed hit compounds.

Discovering Potential Drug Leads via Docking,Synthesis and Bioassay

Fragment-based Drug Discovery and Molecular Docking in Drug Design.

Recent Development and Application of Virtual Screening in Drug Discovery: An Overview

A Comprehensive Survey of Prospective Structure-Based Virtual Screening for Early Drug Discovery in the Past Fifteen Years

Docking-based inverse virtual screening: methods, applications, and challenges

Exploration on Learning Molecular Docking with Deep Learning Models

Advancing Ligand Docking through Deep Learning: Challenges and Prospects in Virtual Screening

Molecular Docking: Shifting Paradigms in Drug Discovery

Virtual Screening on Natural Products for Discovering Active Compounds and Target Information

Molecular docking-based computational platform for high-throughput virtual screening

Efficient Exploration of Chemical Space with Docking and Deep Learning

Docking-based generative approaches in the search for new drug candidates

Molecular Docking: A useful approach of Drug Discovery on the Basis of their Structure

Application of Reverse Docking in the Research of Small Molecule Drugs and Traditional Chinese Medicine.

Recent Advances in Molecular Docking for the Research and Discovery of Potential Marine Drugs

Virtual Screening Methods As Tools For Drug Lead Discovery From Large Chemical Libraries

Virtual Screening Methods As Tools for Drug Lead Discovery from Large Chemical Libraries.

Molecular docking as a popular tool in drug design, an in silico travel

ESSENCE-Dock: A Consensus-Based Approach to Enhance Virtual Screening Enrichment in Drug Discovery

The latest automated docking technologies for novel drug discovery